← Eichor
Study identifier: NCT06683781 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Ventilatory Settings and Monitoring Variables Associated With Weaning Failure in Critically Ill Patients

Condition: Mechanical Ventilation · Weaning Failure · Weaning Failure of Mechanical Ventilation  ·  Sponsor: Hospital Italiano de Buenos Aires

PhaseN/A
Planned participants1077
Who can joinAll sexes, 18 Years to 100 Years
Healthy volunteersNo

About this study

Mechanical ventilation (MV) is essential in managing acute respiratory failure. Its duration is a crucial aspect since both, unnecessary prolongation and premature withdrawal have deleterious effects on patient outcomes in the ICU. The process of weaning refers to the set of procedures and evaluations carried out to discontinue MV. Regardless of the definition used, within the population undergoing weaning, there is a group of patients who successfully pass the daily screening but fail the spontaneous breathing trial (SBT) or the separate attempt (SA). In Argentina, this figure is 39.5%, and 31.4% in patients with COVID-19. On the other hand, another group of patients successfully passes the SA, is extubated, but fails in post-extubation. This failure rate varies in the literature, ranging from approximately 10 to 20%. In our country, this figure is 16% in the general population and rises to 29.7% in COVID-19 patients. Additionally, this population is divided into those who cannot tolerate ventilation without an artificial airway due to upper airway patency issues (such as laryngeal edema), i.e., "airway failure," and those who experience acute respiratory failure. In 2023, the WEAN SAFE study reported novel findings regarding variables associated with weaning failure. In multivariable analysis, it was found that the MV settings and monitoring variables at the time of the first SBT - respiratory rate, positive end-expiratory pressure (PEEP), dynamic airway pressure difference…

This description comes directly from the study's public registry record.

Talk to the study team

Emilio M Steinberg, RT  ·  +54 11 4959-0200  ·  emilio.steinberg@hiba.org.ar

Damián E Steinberg, RT  ·  damianedstein@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Hospital Italiano de Buenos AiresBuenos Aires, ArgentinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06683781